RLFTF
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | -0.36 | $1M | -$4M |
| 2024 Q4 | -1.00 | $3M | $250,000 |
| 2024 Q2 | -0.36 | $6M | -$3M |
| 2023 Q4 | -3.32 | $3M | -$7M |
| 2023 Q2 | -5.10 | $3M | -$11M |
| 2022 Q4 | -2.25 | $3M | -$10M |
| 2022 Q2 | -2.55 | $3M | -$15M |
| 2021 Q4 | -2.10 | $3M | -$18M |